Choosing Healthy Activities and Lifestyle Management Through Portal Support (NCT05410353)
Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
🩺 Plain-English Summary (8th-Grade Level)
The study aims to randomize 250 participants to 1 of 2 arms: a.) an Active Intervention Group (based on the Look AHEAD\* ILI) or b.) a Comparison Group (based on the Look AHEAD DSE Comparison group) to test the hypothesis that a multicomponent, multilevel behavioral weight loss intervention (Active Intervention Group) adapted for different population groups and delivered through Health Information Technology (Health IT) tools via the Electronic Health Record (EHR) patient portal, will result in significantly greater weight loss 12 months after enrollment compared to the Comparison Group. \*The Look AHEAD study was a multi-center, randomized clinical trial involving overweight and obese persons with type 2 diabetes, aimed to determine the effects on the cardiovascular outcomes of an intensive lifestyle intervention (ILI) for weight loss, in comparison to the diabetes support and education intervention (DSE).
Who can join: Review the eligibility criteria below.
Location: University of Tennessee Health Science Center / Department of Preventive Medicine — Memphis, Tennessee
Age range: 16 Years
🧪 Interventions in This Study
- Active Intervention Group (BEHAVIORAL)
- Comparison Group (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Tennessee Health Science Center / Department of Preventive Medicine — Memphis, Tennessee
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Weight Loss
- VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) — Birmingham, Alabama
- Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) — Palo Alto, California
- Risk of Metabolic Adaptation After Weight Loss — Milwaukee, Wisconsin
- Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions — Baltimore, Maryland
- iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families — Kansas City, Kansas
Explore by condition: All Weight Loss clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.